comparemela.com

Page 2 - Tom Schoenherr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OC50 2023: Tom Schoenherr - Orange County Business Journal

Announcing Tom Schoenherr as part of the 2023 OC50 – the 50 individuals shaping the future of healthcare in OC

Unilabs, Ambry Genetics Partner to Market Research-Use Genomic Testing Services Internationally

The companies aim to offer genetic testing for biopharma and government-sponsored research in Europe, Latin America, and the Middle East.

Konica Minolta Precision Medicine to Present on the Future of Integrated Diagnostics at AWS Healthcare & Life Science Virtual Symposium

Konica Minolta Precision Medicine to Present on the Future of Integrated Diagnostics at AWS Healthcare & Life Science Virtual Symposium Tom Schoenherr, CEO of Ambry Genetics, Introduces the LATTICE™ Platform News provided by Share this article Share this article ALISO VIEJO, Calif., May 27, 2021 /PRNewswire/  Konica Minolta Precision Medicine (KMPM), announced today that Tom Schoenherr, Chief Executive Officer of Ambry Genetics, a KMPM company, will present at the third annual AWS Healthcare & Life Science Virtual Symposium on Thursday, May 27, 2021. The presentation will introduce the LATTICE™ platform, a groundbreaking integrated diagnostic data platform combining genomics, pathology, radiology data, and other critical information to uncover new, clinically relevant biomarkers and create the next generation of diagnostic tests. LATTICE leverages machine learning services by combining KMPM s cutting-edge science with the added power of AWS to accelerate drug discovery an

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.